lutetium has been researched along with zoledronic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes, I; Bilewicz, A; Majkowska, A; Neves, M | 1 |
| Ahmadzadehfar, H; Bundschuh, RA; Essler, M; Gaertner, FC; Khawar, A; Kreppel, B; Kürpig, S; Meisenheimer, M; Roesch, F | 1 |
| Flux, G; Liepe, K; Murray, I | 1 |
1 review(s) available for lutetium and zoledronic acid
| Article | Year |
|---|---|
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases.
Topics: Bone and Bones; Bone Neoplasms; Humans; Lutetium; Pain; Radiopharmaceuticals; Rhenium; Tissue Distribution; Zoledronic Acid | 2022 |
2 other study(ies) available for lutetium and zoledronic acid
| Article | Year |
|---|---|
Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy.
Topics: Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Imidazoles; Lutetium; Pain Management; Radioisotopes; Scandium; Zoledronic Acid | 2009 |
[177Lu]Lu-DOTA-zoledronate therapy - first application in a patient with primary osseous metastatic bronchial carcinoma.
Topics: Bone Neoplasms; Carcinoma, Bronchogenic; Humans; Lutetium; Radioisotopes; Zoledronic Acid | 2020 |